These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2510724

  • 21. Stable preparation of aldose reductase isoenzymes from human placenta.
    Fujii Y, Zhao FX, Fu SC, Nakai N, Lai CY.
    Protein Expr Purif; 1991; 2(5-6):420-5. PubMed ID: 1821816
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y, Kador PF, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [Abstract] [Full Text] [Related]

  • 23. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S, Das B, Srivastava SK.
    Lens Eye Toxic Res; 1989 Jan; 6(3):415-30. PubMed ID: 2518623
    [Abstract] [Full Text] [Related]

  • 24. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O, Old SE, Ginell SL, Carper DA.
    Mol Vis; 1999 Sep 03; 5():20. PubMed ID: 10493777
    [Abstract] [Full Text] [Related]

  • 25. Detailed biochemical characterization of human placental cystatin (HPC).
    Rashid F, Sharma S, Bano B.
    Placenta; 2006 Aug 03; 27(8):822-31. PubMed ID: 16271758
    [Abstract] [Full Text] [Related]

  • 26. Rapid purification of human placental aldose reductase.
    Kador PF, Carper D, Kinoshita JH.
    Anal Biochem; 1981 Jun 03; 114(1):53-8. PubMed ID: 6792949
    [No Abstract] [Full Text] [Related]

  • 27. [Analysis of the secondary structure of urokinase by the circular dichroism method].
    Illarionova NG, Kol'tsova SV, Sukhareva TF, Denisov IG, Samsonov GV.
    Mol Biol (Mosk); 1984 Jun 03; 18(2):358-61. PubMed ID: 6717418
    [Abstract] [Full Text] [Related]

  • 28. Secondary structure conversions of Mycobacterium tuberculosis ribonucleotide reductase protein R2 under varying pH and temperature conditions.
    Georgieva ER, Narvaez AJ, Hedin N, Gräslund A.
    Biophys Chem; 2008 Sep 03; 137(1):43-8. PubMed ID: 18657348
    [Abstract] [Full Text] [Related]

  • 29. Quantitation by radioimmunoassay of aldose reductase (ALR2) in normal and diabetic rats.
    McDonald G, Clark AF, Flynn TG.
    Prog Clin Biol Res; 1987 Sep 03; 232():367-75. PubMed ID: 3112789
    [No Abstract] [Full Text] [Related]

  • 30. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr 03; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 31. Optical spectroscopy as an in vitro method to monitor aldose reductase inhibitors in the lens.
    Lerman S, Megaw J, Gardner K.
    Invest Ophthalmol Vis Sci; 1983 Nov 03; 24(11):1505-10. PubMed ID: 6417041
    [Abstract] [Full Text] [Related]

  • 32. Characterization of aldose reductase activities from human and animal sources by a sensitive fluorescence assay.
    Griffin BW, McNatt LG, York BM.
    Prog Clin Biol Res; 1987 Nov 03; 232():325-40. PubMed ID: 3112786
    [No Abstract] [Full Text] [Related]

  • 33. Diabetic cataracts- is aldose reductase important?
    Crabbe MJ, Wolff S, Halder AB, Ting HH.
    Metab Pediatr Ophthalmol; 1981 Nov 03; 5(1):33-8. PubMed ID: 6789018
    [No Abstract] [Full Text] [Related]

  • 34. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    El-Kabbani O, Carbone V, Darmanin C, Oka M, Mitschler A, Podjarny A, Schulze-Briese C, Chung RP.
    J Med Chem; 2005 Aug 25; 48(17):5536-42. PubMed ID: 16107153
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of human placenta aldose reductase by tannic acid.
    Sawada H, Hamatake M, Hara A, Nakagawa M, Nakayama T.
    Chem Pharm Bull (Tokyo); 1989 Jun 25; 37(6):1662-4. PubMed ID: 2505942
    [Abstract] [Full Text] [Related]

  • 36. Localization of aldose and aldehyde reductase in the kidney.
    Terubayashi H, Sato S, Nishimura C, Kador PF, Kinoshita JH.
    Kidney Int; 1989 Nov 25; 36(5):843-51. PubMed ID: 2515341
    [Abstract] [Full Text] [Related]

  • 37. Kinetic and structural effects of activation of bovine kidney aldose reductase.
    Grimshaw CE, Shahbaz M, Jahangiri G, Putney CG, McKercher SR, Mathur EJ.
    Biochemistry; 1989 Jun 27; 28(13):5343-53. PubMed ID: 2550052
    [Abstract] [Full Text] [Related]

  • 38. Characterization of aldose reductase and aldehyde reductase from the medulla of rat kidney.
    Ohta M, Tanimoto T, Tanaka A.
    Chem Pharm Bull (Tokyo); 1990 Jun 27; 38(6):1639-43. PubMed ID: 2119895
    [Abstract] [Full Text] [Related]

  • 39. Localization of aldose reductase in the human eye.
    Akagi Y, Yajima Y, Kador PF, Kuwabara T, Kinoshita JH.
    Diabetes; 1984 Jun 27; 33(6):562-6. PubMed ID: 6427040
    [Abstract] [Full Text] [Related]

  • 40. Human erythrocyte aldose and aldehyde reductase.
    Nakayama T, Tanimoto T, Kador PF.
    Prog Clin Biol Res; 1989 Jun 27; 290():265-77. PubMed ID: 2498902
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.